Abstract
The community of many national and international recommendations dedicated to the treatment of a specific disease, including gout, is fully justified, since it allows taking into account, for example, regional, ethnic characteristics of the manifestations of the disease, which can be important when choosing a therapy. However, this is often associated with dissonance regarding the solution of key issues facing the practitioner. The publication in 2020 of the updated American College of Rheumatology (ACR) guidelines for the management of gout revealed controversy with some of the previous version’s postulates, as well as with other similar work, for example, with the guidelines published in the same year and the French Association of Rheumatology. Among the controversial provisions of the new version of the ACR recommendations are the unified target level of uric acid for all patients, indications for drug therapy, the choice of a drug in patients with reduced renal function, prevention of arthritis attacks when starting uratelowering therapy. This article discusses these and other controversial issues in gout therapy based on an analysis of the latest ACR guidelines.
Highlights
Сосуществование множества национальных и международных рекомендаций, посвященных лечению конкретного заболевания, в том числе подагры, полностью оправдано, так как позволяет учитывать региональные и этнические особенности проявлений болезни, что может быть важным при подборе терапии
The community of many national and international recommendations dedicated to the treatment of a specific disease, including gout, is fully justified, since it allows taking into account, for example, regional, ethnic characteristics of the manifestations of the disease, which can be important when choosing a therapy
The publication in 2020 of the updated American College of Rheumatology (ACR) guidelines for the management of gout revealed controversy with some of the previous version’s postulates, as well as with other similar work, for example, with the guidelines published in the same year and the French Association of Rheumatology
Summary
Сосуществование множества национальных и международных рекомендаций, посвященных лечению конкретного заболевания, в том числе подагры, полностью оправдано, так как позволяет учитывать региональные и этнические особенности проявлений болезни, что может быть важным при подборе терапии. Обновленных рекомендаций Американской коллегии ревматологов (American College of Rheumatology, ACR) по ведению больных подагрой выявила разногласия как с некоторыми постулатами предыдущей версии, так и с другими подобными работами, например, с опубликованными в том же году рекомендациями Французской ассоциации ревматологов.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have